Windtree Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.04-0.04-0.04-0.67
Price/Sales ratio
1.111.09N/AN/A
Earnings per Share (EPS)
$-11.87$-10.97$-11.34$-0.71

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-40.34-6.80-4.74-4.21-19.69-3.84-3.04-0.64-0.15-0.14-0.06-19.69
Price/Sales ratio
626.96380.5891.7252.33226.15579.54N/AN/AN/AN/AN/A579.54
Price/Book Value ratio
92.5745.44-6.49-3.245.931.531.321.030.610.830.161.53
Price/Cash Flow ratio
-43.17-11.21-5.57-3.69-25.62-4.65-3.64-1.83-0.31-0.21-0.13-25.62
Price/Free Cash Flow ratio
-42.37-11.06-5.53-3.68-25.62-4.61-3.60-1.80-0.31-0.21-0.13-25.62
Price/Earnings Growth ratio
1.09-0.730.110.050.26-0.010.06-0.010.000.000.000.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
5.78%5.87%87.51%-1070.10%-490.71%93.59%N/AN/AN/AN/AN/A-490.71%
Operating Profit Margin
-1525.85%-4035.86%-1862.68%-1518.38%-905.76%-12572.22%N/AN/AN/AN/AN/A-905.76%
Pretax Profit Margin
-1554.07%-5589.66%-1933.88%-1242.15%-1148.37%-13876.26%N/AN/AN/AN/AN/A-1148.37%
Net Profit Margin
-1554.07%-5589.66%-1933.88%-1242.15%-1148.37%-15081.81%N/AN/AN/AN/AN/A-1148.37%
Effective Tax Rate
0.04%-8.45%-3.03%-10.79%14.26%-8.68%7.01%12.86%3.36%N/A3.74%-8.68%
Return on Assets
-92.75%-124.32%-407.15%-551.12%-17.19%-25.09%-26.82%-90.43%-103.30%-62.61%-88.54%-25.09%
Return On Equity
-229.48%-667.43%136.97%77.11%-30.14%-39.85%-43.53%-161.49%-391.61%-598.37%-150.45%-39.85%
Return on Capital Employed
-109.04%-119.58%1030.22%268.01%-16.39%-22.39%-28.39%-110.61%-116.44%-61.73%-102.41%-22.39%
Liquidity Ratios
Current Ratio
5.813.680.530.191.243.052.95N/AN/AN/A2.531.24
Quick Ratio
5.813.680.530.191.243.052.954.773.001.342.131.24
Cash ratio
5.713.490.410.150.542.882.764.532.511.082.130.54
Days of Sales Outstanding
-105.70N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
3.68N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
-102.01N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
47.821.28K2.59K64.02118.1849.13K664.20291.0785.653.60KN/A49.13K
Cash Conversion Cycle
-149.84-1.28K-2.59K-64.02-118.18-49.13KN/AN/AN/AN/AN/A-118.18
Debt Ratios
Debt Ratio
0.420.562.574.480.190.040.030.010.010.470.630.19
Debt Equity Ratio
1.063.02-0.86-0.620.330.060.050.010.064.491.760.33
Long-term Debt to Capitalization
0.510.75-6.52-1.680.180.050.03N/AN/A0.810.090.05
Total Debt to Capitalization
0.510.75-6.52-1.680.250.050.040.010.060.810.130.13
Interest Coverage Ratio
-9.41-11.05-15.10-8.97-13.86-53.91-242.53N/AN/AN/A-853.07-53.91
Cash Flow to Debt Ratio
-2.02-1.34-1.34-1.40-0.68-5.17-7.07-28.78-29.65-0.88-7.56-5.17
Company Equity Multiplier
2.475.36-0.33-0.131.751.581.621.783.799.552.761.75
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-14.52-33.94-16.44-14.17-8.82-124.56N/AN/AN/AN/AN/A-8.82
Free Cash Flow / Operating Cash Flow Ratio
1.011.011.001.0011.001.011.011.001.001.001
Cash Flow Coverage Ratio
-2.02-1.34-1.34-1.40-0.68-5.17-7.07-28.78-29.65-0.88-7.56-5.17
Short Term Coverage Ratio
-664.01N/AN/AN/A-1.97-153.18-21.87-28.78-29.65-57.66-20.09-20.09
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A